OCUGEN, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
OCUGEN, INC. (OCGN) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $14.10 million as of 2021-06-30, per its 10-Q filed 2021-08-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2021-08-06
- 2021-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.10M.
- 2021-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.30M.
- 2020-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.10M.
- 2020-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.30M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-06-30 | $14.10M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $9.30M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $1.10M 10-K · filed 2021-03-19 |
| 2020-09-30 | $1.30M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.60M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.40M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $900.00K 10-K · filed 2020-03-27 |
| 2018-12-31 | $2.30M 10-K · filed 2019-03-22 |
| 2018-09-30 | $2.50M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.40M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.40M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.40M 10-K · filed 2019-03-22 |
| 2017-09-30 | $1.70M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.30M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $2.30M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.60M 10-K · filed 2018-03-15 |
| 2016-09-30 | $2.74M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $3.12M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $3.54M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $3.90M 10-K · filed 2017-03-16 |
| 2015-09-30 | $4.44M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.67M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $3.62M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |